YY 0970-2023 Active Industry standards-Medicine

YY 0970-2023 Sterilization of health care products—Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives—Requirements for characterization,development,validation and routine control of a sterilization process for medical device

YY 0970-2023 Sterilization of health care products—Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives—Requirements for characterization,development,validation and routine control of a sterilization process for medical device

Publish Date: 2023-03-14 Implement Date: 2026-05-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Basic Information

Standard Code: YY 0970-2023
Standard Type: Industry standards
Standard Status: Active
is_force_gb: no
CCS Name: Public medical equipment
ICS Name: Integrated disinfection and sterilization
Publish Date: 2023-03-14
Implement Date: 2026-05-01
Publisher: 国家药品监督管理局
Technical Committee: 全国消毒技术与设备标准化技术委员会(SAC/TC 200)
Pages: 36 pages

Scope

本文件规定了对全部或部分来源于动物材料的一次性使用医疗器械进行灭菌的液体化学灭菌剂的特征,以及灭菌开发、确认、过程控制和监控的要求。
本文件适用于液体化学灭菌过程中细菌和真菌污染的风险控制,与其他微生物相关的风险可使用其他方法进行评估(见注1)。
本文件不适用于:
——人体来源的材料;
——病毒和传染性海绵状脑病(TSE)灭活的确认(见注2和注3);
——原生动物和寄生虫灭活或消除的确认;
——生产过程中降低生物负载的处理过程(见注4);
——灭菌过程对医疗器械使用适宜性的测试评估(见注5);
——医疗器械中灭菌剂残留水平的制定(见注6)。
注1: 依据YY/T 0771.1的描述,动物源性医疗器械风险管理原则的优先应用是十分重要的。ISO 18362提供了基于细胞的医疗保健产品生产过程的微生物风险控制。
注2: 液体化学灭菌剂通常用于医疗器械中的动物组织灭菌,可能对传染性海绵状脑病(TSE)例如牛海绵状脑病(BSE)或瘙痒病的致病因子灭活不起作用。因此不宜使用本文件的方法来确认这一类传染因子的灭活。与动物材料的来源、收集与处置相关的风险控制见YY/T 0771.2。
注3: 病毒和TSE致病因子的灭活或/和消除的确认见YY/T 0771.3。
注4: 动物源性医疗器械的生产过程经常包括化学试剂接触,这可以显著减少医疗器械的生物负载。在生产过程之后,医疗器械暴露于特定的灭菌过程中。
注5: 此类试验是医疗器械设计和开发中的关键组成部分。
注6: GB/T 16886.17规定了建立灭菌剂残留可接受限量的方法。

Development Information

Word Count: 63 Thousand words Pages: 36 pages

Replace the following standards

Referenced Standards

中华人民共和国药典 第四部通则 1101无菌检验法 GB/T 16886.1-2001 Biological evaluation of medical devices—Part 1:Evaluation and testing GB/T 16886.1-2011 Biological evaluation of medical devices—Part 1:Evaluation and testing within a risk management process GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1:Evaluation and testing within a risk management process GB/T 16886.17-2005 Biological evaluation of medical devices—Part 17:Establishment of allowable limits for leachable substances GB/T 19973.1-2005 Sterilization of medical devices—Microbiological methods—Part 1:Estimation of population of microorganisms on products GB/T 19973.1-2015 Sterilization of medical devices—Microbiological methods—Part 1:Determination of a population of microorganisms on products GB/T 19973.1-2023 Sterilization of health care products—Microbiological methods—Part 1:Determination of a population of microorganisms on products YY/T 0567.1-2005 Aseptic processing of health care products—Part 1:General requirements YY/T 0567.1-2013 Aseptic processing of health care products—Part 1:General requirements YY/T 0567.2-2005 Aseptic processing of health care products—Part 2:filtration YY/T 0567.2-2021 Aseptic processing of health care products—Part 2:Sterilizing filtration YY/T 0567.3-2011 Aseptic processing of health care products—Part 3:Lyophilization YY/T 0567.4-2011 Aseptic processing of health care products—Part 4:Clean-in-place technologies YY/T 0567.5-2011 Aseptic processing of health care products—Part 5:Sterilization in place YY/T 0567.6-2011 Aseptic processing of health care products—Part 6:Isolator systems YY/T 0567.6-2022 Aseptic processing of health care products—Part 6:Isolator systems YY/T 0567.7-2016 Aseptic processing of health care products—Part 7:Alternative processes for medical devices and combination products GB/T 16886.17-2025 Biological evaluation of medical devices—Part 17:Toxicological risk assessment of medical device constituents

Adopt standards

ISO 14160:2020

Related Standards

Contact Us